A lot of the genetic testing market is built around ancestry as the headline feature, with health information as an add-on. If you're specifically looking for the reverse — comprehensive health, carrier, and pharmacogenomic insight, with ancestry as an afterthought or not a factor at all — the calculus for choosing a test looks different than the typical buying guide assumes.
What Actually Matters for a Health-First Test
- Depth of coverage. SNP-chip based tests (the technology behind most budget ancestry-first kits) check a fixed set of predetermined positions — typically covering a small fraction of clinically relevant genetic variation. Whole genome sequencing reads your complete genome, capturing far more of the carrier status, structural variant, and rare disease information a health-focused buyer actually wants.
- Raw data ownership and reanalysis rights. Genetic science evolves constantly — new gene-disease associations, reclassified variants, expanded pharmacogenomic guidelines. A test that gives you your complete raw data lets you (or a future clinician) re-examine it as science improves, without paying for an entirely new test.
- Pharmacogenomic coverage. If medication response is a priority, confirm the test actually covers major pharmacogenes (like CYP2D6, CYP2C19, and others) rather than just disease-risk SNPs — not every "health" test includes this by default.
- Genetic counseling access. A health-first buyer is more likely to receive a result that warrants professional interpretation. Check whether the company offers counseling access, or at least clear guidance on finding an independent genetic counselor.
Why Whole Genome Sequencing Is the Strongest Health-First Choice
For someone explicitly prioritizing health over ancestry, whole genome sequencing offers the broadest possible foundation: carrier screening across essentially every known gene rather than a fixed panel, pharmacogenomic data, structural variant detection standard SNP arrays miss, and future-proof raw data. Ancestry estimates can still be generated from WGS data if you're curious later — the reverse isn't true for SNP-chip tests, which can't retroactively produce the depth of health data WGS captures natively.
| Test type | Health depth | Ancestry emphasis |
|---|---|---|
| SNP-chip ancestry kits | Limited — fixed marker set | Primary feature |
| Health-focused SNP panels | Moderate — curated condition list | Secondary or absent |
| Whole genome sequencing | Comprehensive — full genome | Optional, generated from the same data |
If health is genuinely your priority, breadth of underlying data matters more than which company's marketing leads with health features. A whole genome test gives you the raw material for both health and ancestry; a SNP-chip ancestry test with a "health" upsell gives you neither at full depth.
Health-First Genetics, Full Depth
Dante Labs' whole genome sequencing is built around comprehensive health, carrier, and pharmacogenomic data — with ancestry available from the same sample if you want it. Use code GENOME for 10% off.
Get Sequenced with Dante Labs → 10% off with code GENOMEFor a deeper look at how WGS compares to narrower testing formats, see our whole genome vs. whole exome guide, and for medication-specific genetics, our pharmacogenomics guide.